Teladoc Health (TDOC) said Thursday it has signed a pharmacy integration agreement with Eli Lilly's (LLY) LillyDirect pharmacy partner Gifthealth to provide self-pay option for obesity drug Zepbound.
The company said its members, who are enrolled in its comprehensive weight care program and don't have insurance coverage for glucagon-like peptide-1 receptor agonists for obesity, can have single-use Zepbound vials delivered to their homes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.